Key result
Modulating the neural pathways involved in glucose homeostasis via bioelectronic medicine presents emerging opportunities for the treatment of type 1 and type 2 diabetes.
Population
Patients with type 1 and type 2 diabetes
Design
Review
Authors
Loading...
CNS modulation may enable bioelectronic glucose control; leaves open translation to practice pending trials.
Bioelectronic medicine targeting the nervous system's role in glucose homeostasis represents a potential future therapeutic pathway for diabetes management.
Güemes et al. (2018) conducted a review in Diabetes. Bioelectronic medicine / Neuromodulation was evaluated. Modulating the neural pathways involved in glucose homeostasis via bioelectronic medicine presents emerging opportunities for the treatment of type 1 and type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: